265 related articles for article (PubMed ID: 23231769)
21. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
22. Notch1 overexpression associates with poor prognosis in human laryngeal squamous cell carcinoma.
Li D; Dong P; Wu C; Cao P; Zhou L
Ann Otol Rhinol Laryngol; 2014 Oct; 123(10):705-10. PubMed ID: 24789803
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor superfamily member 13 is a novel biomarker for diagnosis and prognosis and promotes cancer cell proliferation in laryngeal squamous cell carcinoma.
Wang R; Guo Y; Ma H; Feng L; Wang Q; Chen X; Lian M; Wang H; Fang J
Tumour Biol; 2016 Feb; 37(2):2635-45. PubMed ID: 26395262
[TBL] [Abstract][Full Text] [Related]
24. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Liu Y; Zhang X; Qiu YZ; Huang DH; Zhou XJ; Tan PQ; Cai GM; Dai YZ; Yu CY; Xiao JY; Tian YQ
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):197-201. PubMed ID: 21575519
[TBL] [Abstract][Full Text] [Related]
25. LAMP1 expression is associated with malignant behaviours and predicts unfavourable prognosis in laryngeal squamous cell carcinoma.
Lu M; Zhu H; Wang X; Zhang D; Xiong L; Zhu J; Mao Y; Qiang J
Pathology; 2016 Dec; 48(7):684-690. PubMed ID: 27788920
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC.
Shen Z; Li Q; Deng H; Lu D; Song H; Guo J
PLoS One; 2014; 9(9):e108237. PubMed ID: 25243407
[TBL] [Abstract][Full Text] [Related]
27. Sex-related hormone receptor in laryngeal squamous cell carcinoma: correlation with androgen estrogen-ɑ and prolactin receptor expression and influence of prognosis.
Fei M; Zhang J; Zhou J; Xu Y; Wang J
Acta Otolaryngol; 2018 Jan; 138(1):66-72. PubMed ID: 28889782
[TBL] [Abstract][Full Text] [Related]
28. A correlation analysis between HDAC1 over-expression and clinical features of laryngeal squamous cell carcinoma.
Zhao R; Chen K; Cao J; Yu H; Tian L; Liu M
Acta Otolaryngol; 2016; 136(2):172-6. PubMed ID: 26588579
[TBL] [Abstract][Full Text] [Related]
29. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of mitogen-activated protein kinase kinase 4 and nuclear factor-kappaB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
Huang C; Huang K; Wang C; Jiang ZD; Li XX; Wang HP; Chen HY
Oncol Rep; 2009 Jul; 22(1):89-95. PubMed ID: 19513509
[TBL] [Abstract][Full Text] [Related]
31. [Expression of integrin-linked kinase is closely correlated with laryngeal squamous cell carcinomas].
Wu C; Zhai N; Guan C; Ji W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(9):393-5. PubMed ID: 16836071
[TBL] [Abstract][Full Text] [Related]
32. [Aberrant expression of CyclinE and p27 in laryngeal squamous cell carcinoma and the clinical significance].
Chai D; Bao Z; Hu J; Ma L; Feng Z; Tao Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Feb; 28(3):165-9, 174. PubMed ID: 24826452
[TBL] [Abstract][Full Text] [Related]
33. Competing endogenous RNA network analysis of CD274, IL‑10 and FOXP3 co‑expression in laryngeal squamous cell carcinoma.
Sun J; Lian M; Ma H; Wang R; Ma Z; Wang H; Zhai J; Meng L; Feng L; Bai Y; Cui X; Fang J
Mol Med Rep; 2018 Mar; 17(3):3859-3869. PubMed ID: 29257349
[TBL] [Abstract][Full Text] [Related]
34. Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
Acta Otolaryngol; 2014 Jul; 134(7):753-9. PubMed ID: 24834937
[TBL] [Abstract][Full Text] [Related]
35. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7.
Niu JT; Zhang LJ; Huang YW; Li C; Jiang N; Niu YJ
Biochem Cell Biol; 2018 Dec; 96(6):752-760. PubMed ID: 29874469
[TBL] [Abstract][Full Text] [Related]
36. [Expression of HMGB1 protein in laryngeal squamous cell carcinoma and its clinical significance].
Liu Y; Xie CL; Qiu YZ; Tian YQ; Zhang X; Huang DH; Zhou XJ; Tan PQ; Yu CY; Qi L; Li B; Xiao JY
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):132-6. PubMed ID: 22780932
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between SLP-2 expression and prognosis in laryngeal squamous cell carcinoma and mammary invasive carcinoma].
Cao WF; Zhang LY; Zhang B; Liu MB; Liu ZH; Sun BC
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):332-7. PubMed ID: 20654157
[TBL] [Abstract][Full Text] [Related]
38. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
39. Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma.
Liu XK; Zhang XR; Zhong Q; Li MZ; Liu ZM; Lin ZR; Wu D; Zeng MS
J Transl Med; 2013 Mar; 11():59. PubMed ID: 23497344
[TBL] [Abstract][Full Text] [Related]
40. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]